a07 OLCSG 1b.
Methods | RCT ‐ 1982‐86 | |
Participants | 83 patients | |
Interventions | surgery vs surgery + chemotherapy doxorubicin 100§ mitomycin C 20§ tegafur(a)* 600‐800§ tegafur(b)* 600‐800§ | |
Outcomes | survival | |
Notes | doxorubicin given in 3 cycles tegafur (a) daily treatment tegafur (b) daily treatment > 1 year | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |